These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1355577)

  • 1. Stereospecific effects of ascorbic acid and analogues on D1 and D2 agonist binding.
    Tolbert LC; Morris PE; Spollen JJ; Ashe SC
    Life Sci; 1992; 51(12):921-30. PubMed ID: 1355577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of selective D1 and D2 dopamine receptor agonists in the medial prefrontal cortex of young and aged Fischer 344 rats.
    Parfitt KD; Gratton A; Bickford-Wimer PC
    J Pharmacol Exp Ther; 1990 Aug; 254(2):539-45. PubMed ID: 1974642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of locally applied D1 and D2 agonists on striatal neurons with 6-OHDA and pertussis toxin lesions.
    Strömberg I; Bickford-Wimer P
    Brain Res; 1991 Nov; 564(2):279-85. PubMed ID: 1687374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
    Panagopoulos NT; Matsokis NA; Valcana T
    J Neurosci Res; 1993 Aug; 35(5):499-506. PubMed ID: 8377223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of both D1 and D2 dopamine receptors increases behavioral activation and ascorbate release in the neostriatum of freely moving rats.
    Pierce RC; Rebec GV
    Eur J Pharmacol; 1990 Dec; 191(3):295-302. PubMed ID: 1982267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the central and renal dopamine-1 receptor.
    Sidhu A; Felder RA; Jose PA; Fishman PH
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):37S-39S. PubMed ID: 1974441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice.
    Winkler JD; Weiss B
    J Pharmacol Exp Ther; 1989 May; 249(2):507-16. PubMed ID: 2566677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of dopamine synthesis in striatal slices by the D1 agonist SKF 38393 is not mediated by D1 dopamine receptors.
    Brooderson RJ; White FJ; Galloway MP
    Synapse; 1990; 6(4):395-7. PubMed ID: 2287994
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pertussis toxin on caudate neuron electrophysiology: studies with dopamine D1 and D2 agonists.
    Bickford-Wimer P; Kim M; Boyajian C; Cooper DM; Freedman R
    Brain Res; 1990 Nov; 533(2):263-7. PubMed ID: 1981169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain.
    Undie AS; Friedman E
    J Pharmacol Exp Ther; 1990 Jun; 253(3):987-92. PubMed ID: 1972756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACTH/MSH-like peptides inhibit the binding of dopaminergic ligands to the dopamine D2 receptor in vitro.
    Florijn WJ; De Boer T; Tonnaer JA; Van Nispen JW; Versteeg DH
    Eur J Pharmacol; 1991 May; 207(1):43-50. PubMed ID: 1680721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.